Evidence map›Paper›PMID 22956818›Full record

ArticleJournal of the American Society of Nephrology : JASN2012

Nanoparticle-based test measures overall propensity for calcification in serum.

Andreas Pasch, Stefan Farese, Steffen Gräber, Johanna Wald, Walter Richtering, Jürgen Floege, Willi Jahnen-Dechent

2 registry-linked trialsAbstract readEvaluation StudyValidation Study
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 180 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02241109 nacompletednot on this mapstarted 2014, after this paper: background citation

Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity

TypeinterventionalSponsorInsel Gruppe AG, University Hospital BernRan2014 to 2017Enrolled200ConditionsAortic Valve Sclerosis, Aortic Valve Stenosis, Stenosis Progression, Valvular Heart DiseaseArmsno intervention
NCT02621762 nacompletednot on this mapstarted 2015, after this paper: background citation

Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum

TypeinterventionalSponsorInsel Gruppe AG, University Hospital BernRan2015 to 2016Enrolled12ConditionsEnd Stage Renal Failure on Dialysis, Vascular CalcificationArmsMagnesium, Bicarbonate
3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 2 syntheses or guidelines pooled it, 330 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects.Journal of the American Society of Nephrology : JASN · 2018
    Trial
  11. Trial
  12. Trial
  13. Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Trial
  14. Trial
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Andreas PaschDepartment of Nephrology and Hypertension, University Hospital and University of Bern, Inselspital, 3010 Bern, Switzerland. andreas.pasch@insel.ch
Stefan Farese
Steffen Gräber
Johanna Wald
Walter Richtering
Jürgen Floege
Willi Jahnen-Dechent
Institute for Biomedical Engineering · CHInstitute of Physical Chemistry · PLUniversity Hospital of Bern · CHUniversity of Bern · CHWestfälische Hochschule · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular and soft tissue calcification contributes to cardiovascular morbidity and mortality in both the general population and CKD. Because calcium and phosphate serum concentrations are near supersaturation, the balance of inhibitors and promoters critically influences the development of calcification. An assay that measures the overall propensity for calcification to occur in serum may have clinical use. Here, we describe a nanoparticle-based assay that detects, in the presence of artificially elevated calcium and phosphate concentrations, the spontaneous transformation of spherical colloidal primary calciprotein particles (CPPs) to elongate crystalline secondary CPPs. We used characteristics of this transition to describe the intrinsic capacity of serum to inhibit the precipitation of calcium and phosphate. Using this assay, we found that both the sera of mice deficient in fetuin-A, a serum protein that inhibits calcification, and the sera of patients on hemodialysis have reduced intrinsic properties to inhibit calcification. In summary, we developed a nanoparticle-based test that measures the overall propensity for calcification in serum. The clinical use of the test requires evaluation in a prospective study.

Indexed as

Nanoparticlesalpha-2-HS-GlycoproteinAnimalsCalcinosisCalciumCase-Control StudiesChemical PrecipitationColloidsCrystallizationHumansLightMiceMice, Inbred DBAMice, KnockoutNanotechnologyNephelometry and TurbidimetryAhsg protein, mousealpha-2-HS-GlycoproteinCalciumColloidsPhosphates

Identifiers

PMID22956818
PMCPMC3458464
OpenAlexW2158561625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.